['chronic obstructive pulmonary disease']
['glycopyrronium mdi 28.8 micrograms', 'glycopyrronium mdi 14.4 micrograms', 'glycopyrronium mdi 7.2 micrograms', 'placebo mdi']

        Inclusion Criteria:

          -  Clinical history of COPD with a moderate to severe classification

          -  Current and former smokers with a history of at least 10 pack-years of cigarette
             smoking.

        -Post-bronchodilator FEV1 must be ≥30% and <80% predicted normal value-

        Exclusion Criteria:

          -  Pregnancy

          -  Primary asthma diagnosis; Poorly controlled COPD defined as acute worsening of COPD
             that required treatment with corticosteroids or antibiotics in the 6-week interval
             prior to Screening or between Screening and Visit 2;

          -  Clinically significant abnormal ECG

          -  Other active pulmonary disease such as active tuberculosis, lung cancer,
             bronchiectasis, sarcoidosis, lung fibrosis, primary pulmonary hypertension,
             interstitial lung disease, and uncontrolled sleep apnea; Cancer that was not in
             complete remission for at least 5 years;

          -  Diagnosis of angle closure glaucoma

          -  A documented myocardial infarction within 1 year of Screening.
      